| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±1.8% | -0.8% | over-priced |
| 05/01/2026 | ±1.7% | -0.2% | over-priced |
| 11/04/2025 | ±1.9% | -0.0% | over-priced |
| 08/05/2025 | ±2.1% | -1.0% | over-priced |
| 05/01/2025 | ±2.3% | +0.9% | over-priced |
| 10/30/2024 | ±1.6% | +0.7% | over-priced |
| 08/02/2024 | ±2.3% | -4.2% | under-priced |
| 05/01/2024 | ±1.3% | +0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $7.70 | $57.3B | $21.2B |
| Q1 FY2026 | $5.94 | $49.8B | $16.5B |
| Q4 FY2025 | $4.64 | $45.8B | $13.0B |
| Q3 FY2025 | $5.07 | $46.4B | $14.4B |
JPMorgan Chase & Co. (JPM) reports in 81 days, with the next report estimated for 11/29/2026. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced JPM's earnings risk. Fundamentals into the print: EPS up 46.9% year-over-year, revenue up 27.7%. QuantLogix's live 5-factor engine currently reads JPM as a strong buy at 58/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →